Kornitzer Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$65.5M Sell
544,161
-8,798
-2% -$1.02M 1.41% 14
2025
Q4
$58.2M Buy
552,959
+7,905
+1% +$742K 1.21% 17
2025
Q3
$45.7M Buy
545,054
+6,788
+1% +$559K 0.92% 25
2025
Q2
$42.6M Buy
538,266
+11,234
+2% +$893K 0.86% 27
2025
Q1
$47.3M Sell
527,032
-11,457
-2% -$1.07M 0.98% 24
2024
Q4
$53.6M Sell
538,489
-9,692
-2% -$999K 1.05% 19
2024
Q3
$62.3M Buy
548,181
+1,291
+0.2% +$153K 1.15% 13
2024
Q2
$67.7M Buy
546,890
+1,701
+0.3% +$219K 1.28% 12
2024
Q1
$71.9M Sell
545,189
-8,132
-1% -$1M 1.32% 10
2023
Q4
$60.3M Sell
553,321
-5,295
-0.9% -$550K 1.17% 13
2023
Q3
$57.5M Sell
558,616
-6
-0% -$647 1.19% 12
2023
Q2
$64.5M Sell
558,622
-2,381
-0.4% -$270K 1.27% 11
2023
Q1
$59.7M Sell
561,003
-4,016
-0.7% -$434K 1.19% 10
2022
Q4
$62.7M Sell
565,019
-3,398
-0.6% -$347K 1.27% 10
2022
Q3
$49M Sell
568,417
-8,404
-1% -$750K 1.05% 17
2022
Q2
$52.6M Sell
576,821
-4,140
-0.7% -$367K 1.05% 14
2022
Q1
$47.7M Buy
580,961
+1,740
+0.3% +$137K 0.79% 22
2021
Q4
$44.4M Buy
579,221
+102
+0% +$8.12K 0.66% 26
2021
Q3
$43.5M Buy
579,119
+182
+0% +$13.8K 0.67% 20
2021
Q2
$45M Sell
578,937
-21,244
-4% -$1.58M 0.68% 20
2021
Q1
$44.1M Buy
600,181
+15,326
+3% +$1.13M 0.71% 22
2020
Q4
$45.6M Sell
584,855
-4,538
-0.8% -$347K 0.77% 18
2020
Q3
$46.7M Sell
589,393
-13,362
-2% -$1.05M 0.91% 14
2020
Q2
$44.5M Sell
602,755
-2,368
-0.4% -$178K 0.9% 13
2020
Q1
$44.4M Sell
605,123
-12,733
-2% -$1M 1.05% 8
2019
Q4
$53.6M Sell
617,856
-21,855
-3% -$1.8M 0.95% 11
2019
Q3
$51.4M Sell
639,711
-18,141
-3% -$1.45M 0.93% 14
2019
Q2
$52.6M Sell
657,852
-14,981
-2% -$1.15M 0.93% 14
2019
Q1
$53.4M Sell
672,833
-7,764
-1% -$581K 0.96% 12
2018
Q4
$49.6M Sell
680,597
-8,997
-1% -$635K 0.99% 12
2018
Q3
$46.7M Sell
689,594
-4,392
-0.6% -$280K 0.74% 25
2018
Q2
$40.2M Sell
693,986
-56,504
-8% -$3.19M 0.67% 36
2018
Q1
$39M Sell
750,490
-19,990
-3% -$1.08M 0.67% 35
2017
Q4
$41.4M Sell
770,480
-90,385
-10% -$5.01M 0.7% 27
2017
Q3
$52.6M Sell
860,865
-18,831
-2% -$1.14M 0.92% 19
2017
Q2
$53.8M Sell
879,696
-5,455
-0.6% -$332K 0.94% 15
2017
Q1
$53.7M Sell
885,151
-1,316
-0.1% -$79.8K 0.96% 17
2016
Q4
$49.8M Sell
886,467
-1,626
-0.2% -$95.2K 0.93% 22
2016
Q3
$52.9M Buy
888,093
+9,039
+1% +$529K 0.95% 17
2016
Q2
$48.3M Sell
879,054
-3,589
-0.4% -$191K 0.87% 20
2016
Q1
$44.6M Buy
882,643
+8,337
+1% +$408K 0.77% 24
2015
Q4
$44.1M Buy
874,306
+4,629
+0.5% +$233K 0.72% 28
2015
Q3
$41M Buy
869,677
+114,483
+15% +$6.08M 0.65% 39
2015
Q2
$41M Sell
755,194
-6,103
-0.8% -$342K 0.56% 55
2015
Q1
$41.8M Sell
761,297
-19,587
-3% -$1.11M 0.5% 73
2014
Q4
$42.3M Sell
780,884
-2,808
-0.4% -$156K 0.49% 77
2014
Q3
$44.3M Sell
783,692
-2,980
-0.4% -$167K 0.51% 71
2014
Q2
$43.4M Sell
786,672
-5,313
-0.7% -$290K 0.47% 77
2014
Q1
$42.9M Sell
791,985
-4,087
-0.5% -$212K 0.45% 75
2013
Q4
$38M Buy
796,072
+411,549
+107% +$18.8M 0.41% 78
2013
Q3
$17.5M Sell
384,523
-733
-0.2% -$33.5K 0.2% 132
2013
Q2
$17.1M Buy
+385,256
New +$17.2M 0.22% 131

Other funds holding MRK

Kornitzer Capital Management's MRK Position: Q1 2026 in Review

Kornitzer Capital Management reduced its Merck (MRK) stake by 1.6% in Q1 2026, selling an estimated $1.02M and leaving 544,161 shares worth $65.5M. The position accounts for 1.41% of the portfolio, ranked #14.

Kornitzer Capital Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $71.9M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Kornitzer Capital Management held 544,161 shares of Merck worth $65.5M as of Q1 2026.
  • Kornitzer Capital Management sold 8,798 Merck shares in Q1 2026, an estimated $1.02M.
  • Merck made up 1.41% of Kornitzer Capital Management's portfolio in Q1 2026, its #14 holding.
  • Kornitzer Capital Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Kornitzer Capital Management's Merck position peaked at $71.9M in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Kornitzer Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.